AccelRX.ai
AccelRx.ai is an AI agent that runs the full prior-authorization workflow for specialty clinics, chart intake, policy research, form fill,
About
Prior authorization is the largest operational tax on specialty prescribing : every case takes 30-60 minutes of clinic staff time, approval rates suffer because chart-to-policy fit goes unresearched, and denials trigger a paper-based appeal cycle that frequently gets abandoned. AccelRx.ai is an AI agent that runs the entire PA workflow autonomously. It reads the chart note, matches the payer-specific coverage policy, fills the CoverMyMeds form using clinical evidence pulled from the chart, submits to the payer, and drafts an appeal letter when denied by citing the patient's actual chart and the payer's own published criteria.
Key facts
- Website
- accelrx.ai
- Headquarters
- San Francisco, United States
- Founded
- 2022
- Total funding
- $2M (Seed)
- Valuation
- Private
- Business model
- B2B
- Tags
- AI AgentsHealthTechWorkflow AutomationRevenue Cycle ManagementClinical Operations
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2023 | Seed | $2M | HealthTech Ventures |
Tech stack
Detected on accelrx.ai, last scanned 3 Jul 2026. Run your own scan
- Compliance
- SOC 2, HIPAA
- Frontend
- Next.js, Tailwind CSS
- Hosting
- Google Cloud
- Email provider
- Google Workspace
Frequently asked
How much funding has AccelRX.ai raised?
AccelRX.ai has raised a total of $2M in funding. The most recent round on record is Seed.
What is AccelRX.ai's current status?
AccelRX.ai's current operating status is: Inactive.